EP2042191
Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.9.2008EP published:
2.1.2013EP application number:
08164900.6
EPO information:
European Patent Register
Max expiry date:
22.9.2028
Title:
Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination
Timeline
Today
23.9.2008EP application
2.1.2013EP Publication
Owner
Name:
Chiarle, RobertoAddress:
Corso Vittorio Veneto, 70, 12038, Savigliano (CN), IT
Name:
Inghirami, GiorgioAddress:
Frazione Ranello, 71, 14022, Castelnuovo Don Bosco (AT), IT
Name:
Forni, GuidoAddress:
Via dei Mille, 32, 10123, Torino, IT
Inventor
Name:
Chiarle, RobertoAddress:
Savigliano (CN), IT
Name:
Inghirami, GiorgioAddress:
Castelnuovo Don Bosco (AT), IT
Name:
Forni, GuidoAddress:
Torino, IT
Priority
Number:
960414 PDate:
28.9.2007Country:
US
Classification
Categories:
A61K 39/00, A61P 35/00